AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2017

Feb 14, 2017

35134_dirs_2017-02-14_a7d2ee6a-a3a9-42a0-b67f-02d9b0d60b15.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2016-12-31

Reporting Person: Finizio Robert G (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-29	Common Stock	G	165000	—	Disposed	18651059	Direct
2016-12-30	Common Stock	G	7500	—	Disposed	18643559	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1827440	Indirect
Common Stock	172560	Indirect

Footnotes

F1: Includes 20,000 shares of Common Stock that were inadvertently reported as being disposed of by gift on the Reporting Person's Form 5 filed with the SEC on February 16, 2016.

F2: By the Reporting Person's Grantor-Retained Annuity Trust (the "Finizio GRAT").

F3: By Robert Finizio Revocable Trust; these shares were previously reported as held by the Finizio GRAT.